About Cil Laboratories Private Limited
Data last updated:
Cil Laboratories Private Limited is a private limited company based in Kolkata, West Bengal, India, a subsidiary of Cenosphere India Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U36999WB2016PTC216162. Its GSTIN is 19AAGCC5034R2Z3 (West Bengal). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.71 Cr. It is led by directors including Santanu Bakshi and Sharad Kumar Agarwal.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Agarwal House 2nd Georges Gate Road Hastings 2nd Floor, Kolkata, West Bengal, India – 700022.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹7.02 Lakh (net margin 2.2%) and EBITDA of ₹61.66 Lakh (EBITDA margin 19.6%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹5.85 Cr and satisfied charges of ₹60 Lakh on record. Court records list 9 cases involving the company, including 3 filed by the company and 6 filed against it; 4 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2022. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Basr Fine Chemicals Private Limited with revenue of ₹3.32 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cillaboratories.com.
Company details
Contact details
Cil Laboratories Private Limited's registered office is in Kolkata, West Bengal. Its website is cillaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressAgarwal House 2nd Georges Gate Road Hastings 2nd Floor, Kolkata, West Bengal, India – 700022
- IndustryPharma, API Manufacturers
To see the full contact details of Cil Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cil Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cil Laboratories Private Limited, buy the company report.
Financials of Cil Laboratories Private Limited
FY 2024 filings availableCil Laboratories Private Limited reported revenue of ₹3.14 Cr (up 26590% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.14 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.6% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cil Laboratories Private Limited, buy the company report.
Board of directors of Cil Laboratories Private Limited
Cil Laboratories has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santanu Bakshi Also directs: Showering Snow Private Limited, Unifour Comercio Private Limited | Director | 20 Mar 2017 | 9 Years 7 Months | Current |
| Sharad Kumar Agarwal | Director | 30 Mar 2023 | 3 Years 6 Months | Current |
| Siddharth Tibrewal Also directs: Adresc Infraprojects LLP, Foryour Resque Private Limited | Director | 09 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Cil Laboratories Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Basr Fine Chemicals Private Limited | ₹3.32 Cr (FY 2025) | 190.0% | Telangana, India | |||
| Abhelfen Life Science Private Limited | ₹3.23 Cr (FY 2025) | 404.0% | Gandhinagar, Gujarat, India | |||
| Maruti Futuristic Pharma Private Limited | ₹3.2 Cr (FY 2025) | -25.0% | Bangalore, Karnataka, India | |||
| Mekanar Pharma Private Limited | ₹3.2 Cr (FY 2025) | 50.0% | Hyderabad, Telangana, India | |||
| Cil Laboratories Private Limitedthis company | ₹3.14 Cr (FY 2023) | ₹7.02 Lakh | 2.2% | 26590.0% | Kolkata, West Bengal, India | |
| Vvic Pharma Private Limited | ₹3.14 Cr (FY 2025) | 303.0% | Ankleshwar, Gujarat, India | |||
| Sthree Chemicals Private Limited | ₹3.11 Cr (FY 2024) | -53.0% | Walajapet, Tamil Nadu, India | |||
| Supreme Drugs Private Limited | ₹3.08 Cr (FY 2024) | 1350.0% | Banaskatha, Gujarat, India | |||
| Innosyn Life Sciences Private Limited | ₹3.04 Cr (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Nic Bioscience Private Limited | ₹3.03 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Cil Laboratories Private Limited, buy the company report.
Auditor
Cil Laboratories Private Limited is audited by V.K.PATWARI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.K.PATWARI & CO | FY 2023 | 324476E |
Shareholding
The shareholding of Cil Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cil Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2025 | 101060871 | Indian Overseas Bank | ₹50 Lakh | Open | |
| 04 Nov 2022 | 100643489 | Indian Overseas Bank | ₹5.25 Cr | Open | |
| 21 May 2022 | 100575994 | Others | ₹10.2 Lakh | Open | |
| 05 Jan 2019 | 100242276 | Others | ₹60 Lakh | Satisfied |
To see the full charge records of Cil Laboratories Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Cil Laboratories Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Cenosphere India Private Limited Seller: an individual |
| Aug 2021 | Rights issue | ₹2.66 Cr | Investors: Cenosphere India Private Limited , an individual |
| Feb 2020 | Rights issue | ₹55 Lakh | Investors: Cenosphere India Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cil Laboratories Private Limited has 9 court cases on record: 3 filed by Cil Laboratories, 6 filed against it. 4 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 6 | 4 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Siemens Financial Services Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case SC) | Filed against the company by Astec Lifesciences Limited | Disposed |
| District court, Central, Delhi | Cheque dishonour complaint | Filed against the company by Insta Chemi Private Ltd | Disposed |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against an individual | Disposed |
| District court, Rangareddy, Telangana | Criminal complaint | Filed by the company against M/S.Sigma Biochem Rep by Prop Sudarshan Gopal | Disposed |
To see the full case history of Cil Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Cil Laboratories Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rishon Laboratories Private Limited | |||
| NK Chemicals Pvt Ltd |
To see the full MSME payment records of Cil Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cil Laboratories Private Limited has 1 active EPFO establishment as of Mar 27, 2024.
GST
Cil Laboratories has 5 GST registrations: 3 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCC5034R2Z3 | West Bengal | Active | 29 Feb 2020 |
| 36AAGCC5034R2Z7 | Telangana | Active | 01 Jul 2017 |
| 29AAGCC5034R1Z3 | Karnataka | Active | 16 Dec 2021 |
To see the full GST registrations and return filing status of Cil Laboratories Private Limited, buy the company report.
Recent activity
Cil Laboratories Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Sharad Kumar Agarwal was appointed as Director on 30 Mar 2023.
6 earlier events are in the company report.
Frequently asked questions
Cil Laboratories is an active private limited company based in Kolkata, West Bengal, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 June 2016 (10+ years old) and is registered under CIN U36999WB2016PTC216162.
Cil Laboratories has 3 current directors:
- Santanu Bakshi - Director
- Sharad Kumar Agarwal - Director
- Siddharth Tibrewal - Director
The latest financial statements of Cil Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Cil Laboratories is 19AAGCC5034R2Z3, registered in West Bengal. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 36AAGCC5034R2Z7 (Telangana), 29AAGCC5034R1Z3 (Karnataka).
The CIN (Corporate Identification Number) of Cil Laboratories is U36999WB2016PTC216162. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cil Laboratories has 9 court cases on record: 3 filed by the company and 6 filed against it. 4 are pending.
Cil Laboratories was incorporated on 14 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
Cil Laboratories has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2022.
The peers of Cil Laboratories by revenue are Basr Fine Chemicals Private Limited, Abhelfen Life Science Private Limited, Maruti Futuristic Pharma Private Limited, Mekanar Pharma Private Limited, Vvic Pharma Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sharad Kumar Agarwal was appointed as Director on 30 Mar 2023. Rakesh Agarwal ceased to be Additional Director on 20 Oct 2021. Siddharth Tibrewal ceased to be Additional Director on 20 Oct 2021. Cil Laboratories has 8 board changes on record in total.
Cil Laboratories has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers. The latest return was filed on 18 Oct 2019.
Cil Laboratories can be reached through the website cillaboratories.com. Its registered office is in Kolkata, West Bengal, India.